Stocks and Investing Stocks and Investing
Wed, November 3, 2021
[ 12:00 AM ] - WOPRAI
Thomas Champion Downgraded (Z) to Hold and Decreased Target to $78 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Downgraded (Z) to Hold and Held Target at $89 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Naved Khan Downgraded (Z) to Hold and Decreased Target to $83 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Ronald Josey Downgraded (Z) to Hold on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jake Fuller Downgraded (Z) to Hold on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (Z) at Buy with Decreased Target to $100 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Tom White Maintained (Z) at Strong Buy with Decreased Target to $125 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jason Kreyer Maintained (Z) at Strong Buy with Decreased Target to $95 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Thomas Champion Downgraded (ZG) to Hold and Decreased Target to $78 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Downgraded (ZG) to Hold and Held Target at $89 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Naved Khan Downgraded (ZG) to Hold and Decreased Target to $83 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Ronald Josey Downgraded (ZG) to Hold on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jake Fuller Downgraded (ZG) to Hold on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (ZG) at Buy with Decreased Target to $100 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Tom White Maintained (ZG) at Strong Buy with Decreased Target to $125 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jason Kreyer Maintained (ZG) at Strong Buy with Decreased Target to $95 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Maintained (AJG) at Buy with Increased Target to $180 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Andrew Bauch Initiated (AFRM) at Buy and Held Target at $220 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
George Hill Maintained (AGL) at Strong Buy with Decreased Target to $36 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (AKAM) at Hold with Increased Target to $130 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Shebly Seyrafi Maintained (AKAM) at Buy with Increased Target to $135 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
James Fish Maintained (AKAM) at Buy with Increased Target to $133 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jiong Shao Initiated (BEKE) at Buy and Held Target at $29 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Kurt Yinger Maintained (BCC) at Hold with Increased Target to $72 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Gregory Zhao Initiated (BIDU) at Buy and Held Target at $243 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Douglas Miehm Maintained (BHC) at Buy with Decreased Target to $40 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (BFAM) at Sell with Decreased Target to $130 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Mike Cyprys Maintained (BEN) at Sell with Increased Target to $30 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Timothy Horan Maintained (APPS) at Buy with Increased Target to $117 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Kennen MacKay Maintained (ADCT) at Buy with Increased Target to $34 on, Nov 3rd, 2021

Kennen MacKay Maintained (ADCT) at Buy with Increased Target to $34 on, Nov 3rd, 2021


Published on 2024-10-27 18:29:06 - WOPRAI, Kennen MacKay
  Print publication without navigation


Kennen MacKay of RBC Capital, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Increased Target from $33 to $34 on, Nov 3rd, 2021.

Kennen has made no other calls on ADCT in the last 4 months.



There is 1 other peer that has a rating on ADCT. Out of the 1 peers that are also analyzing ADCT, 0 agree with Kennen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kennen

  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $47 on, Tuesday, September 7th, 2021
Contributing Sources